$KLTO
Stock $klto

$klto Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000121390023028625 Filed on April 10, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$358.0K	$239.5K	$657.0K
YoY Change	53.8%
% of Gross Profit
Research & Development	$0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$358.0K	$239.5K	$657.0K
YoY Change	53.8%		18355.62%
Operating Profit	-$358.0K		-$657.0K
YoY Change	53.8%
Interest Expense	$399.6K	$1.119M	$1.578M
YoY Change	172.92%
% of Operating Profit
Other Income/Expense, Net	-$21.20K	$0.00	$555.9K
YoY Change	-82.69%
Pretax Income	$20.40K	$879.4K	$1.476M
YoY Change	-109.77%
Income Tax	$173.9K	$163.3K	$243.1K
% Of Pretax Income	852.69%	18.57%	16.46%
Net Earnings	-$153.5K	$716.1K	$1.233M
YoY Change	-26.47%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share	-$0.02	$0.05	$0.10
COMMON SHARES
Basic Shares Outstanding	8.802M shares	14.91M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.7K	$341.0K	$341.0K
YoY Change	-72.35%		6788.08%
Cash & Equivalents	$123.7K	$341.0K
Short-Term Investments
Other Short-Term Assets	$135.2K	$99.20K	$99.20K
YoY Change	-38.03%
Inventory
Prepaid Expenses	$135.2K	$99.20K
Receivables
Other Receivables
Total Short-Term Assets	$258.9K	$440.2K	$440.2K
YoY Change	-61.1%	8788.49%	8792.12%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$56.95M	$117.8M	$117.8M
YoY Change	-51.03%
Other Assets
YoY Change
Total Long-Term Assets	$56.95M	$117.8M	$117.8M
YoY Change	-51.03%
TOTAL ASSETS
Total Short-Term Assets	$258.9K	$440.2K	$440.2K
Total Long-Term Assets	$56.95M	$117.8M	$117.8M
Total Assets	$57.21M	$118.2M	$118.2M
YoY Change	-51.09%	2387756.14%	2388721.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$273.5K	$140.4K	$263.2K
YoY Change	811.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.352M	$506.2K	$506.2K
YoY Change	1850.48%	5848.08%	4962.4%
LONG-TERM LIABILITIES
Long-Term Debt	$870.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.376M	$4.344M	$4.344M
YoY Change	-12.87%
Total Long-Term Liabilities	$5.246M	$4.344M	$4.344M
YoY Change	4.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.352M	$506.2K	$506.2K
Total Long-Term Liabilities	$5.246M	$4.344M	$4.344M
Total Liabilities	$6.726M	$4.929M	$4.930M
YoY Change	32.09%	57819.12%	49195.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.046M	-$4.045M
YoY Change	41.25%	113551.36%
Common Stock	$340.00	$340.00
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.046M	-$4.045M	$113.3M
YoY Change
Total Liabilities & Shareholders Equity	$57.21M	$118.2M	$118.2M
YoY Change	-51.09%	2387756.14%	2388721.01%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$153.5K	$716.1K	$1.233M
YoY Change	-26.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$513.5K	-$73.18K	-$493.0K
YoY Change	30.69%		-10060.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$63.33M	$0.00	-$116.2M
YoY Change	-154.52%
Cash From Investing Activities	$63.33M	$0.00	-$116.2M
YoY Change	-154.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-62.81M	0.000	$117.0M
YoY Change	-153.69%
NET CHANGE
Cash From Operating Activities	-513.5K	-73.18K	-$493.0K
Cash From Investing Activities	63.33M	0.000	-$116.2M
Cash From Financing Activities	-62.81M	0.000	$117.0M
Net Change In Cash	5.740K	-73.18K	$336.0K
YoY Change	-98.7%		6688.08%
FREE CASH FLOW
Cash From Operating Activities	-$513.5K	-$73.18K	-$493.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent		usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	rwod	Deferred Underwriting Fee Payables DeferredUnderwritingFeePayables		usd
	us-gaap	Franchisor Costs FranchisorCosts		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	dei	Entity Public Float EntityPublicFloat	113600000	usd
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41340
CY2022	dei	Entity Registrant Name EntityRegistrantName	REDWOODS ACQUISITION CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2727441
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1115 Broadway
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10010
CY2022	dei	City Area Code CityAreaCode	(646)
CY2022	dei	Local Phone Number LocalPhoneNumber	916-5315
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	RWOD
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8801650	shares
CY2022	dei	Auditor Name AuditorName	Friedman LLP
CY2022	dei	Auditor Firm AuditorFirmId	711
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash Cash	340962	usd
CY2021Q4	us-gaap	Cash Cash	4952	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	99196	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	440158	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4952	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	117806478	usd
CY2022Q4	us-gaap	Assets Assets	118246636	usd
CY2021Q4	us-gaap	Assets Assets	4952	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	140370	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	122801	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	243070	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	8511	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	506241	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8511	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	31800	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	78955	usd
CY2022Q4	rwod	Deferred Underwriting Fee Payables DeferredUnderwritingFeePayables	4312500	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4929496	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8511	usd
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	11500000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	11500000	shares
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.21
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.21
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	117361652	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3405000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3405000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	340	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4044852	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3559	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4044512	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3559	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118246636	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4952	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	533992	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3559	usd
CY2022	us-gaap	Franchisor Costs FranchisorCosts	123026	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-657018	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3559	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1280500	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	375978	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-555917	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1555377	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3559	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-78955	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	243070	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1233352	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3559	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3559	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	115000000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	5300000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	100	usd
CY2022	rwod	Stock Issued During Period Value Underwriter Commissions StockIssuedDuringPeriodValueUnderwriterCommissions	-7187500	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-462536	usd
CY2022	rwod	Stock Issued During Period Value Warrant Liabilities StockIssuedDuringPeriodValueWarrantLiabilities	-587717	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	94875000	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	6901405	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	29388057	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1233352	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4044512	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3559	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3559	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1233352	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3559	usd
CY2022	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	1656478	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-555917	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	99196	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	140370	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	122801	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	243070	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	78955	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	8511	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-493043	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4952	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	116150000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116150000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	115000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5300000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	200000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	8511	usd
CY2022	rwod	Payment Of Underwriters Commissions PaymentOfUnderwritersCommissions	2875000	usd
CY2022	rwod	Payment Of Deferred Offering Costs PaymentOfDeferredOfferingCosts	462536	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	116979053	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	336010	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4952	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	340962	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952	usd
CY2022	rwod	Initial Classification Of Common Stock Subject To Redemption InitialClassificationOfCommonStockSubjectToRedemption	94873850	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	587717	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	4312500	usd
CY2022	rwod	Allocation Of Offering Costs To Common Stock Subject To Redemption AllocationOfOfferingCostsToCommonStockSubjectToRedemption	6901405	usd
CY2022	rwod	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	29388057	usd
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q2	rwod	Gross Proceeds GrossProceeds	100000000	usd
CY2022Q2	rwod	Total Gross Proceeds TotalGrossProceeds	4775000	usd
CY2022	rwod	Additional Public Units AdditionalPublicUnits	1500000	shares
CY2022Q2	rwod	Purchased Public Units PurchasedPublicUnits	1500000	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q2	rwod	Gross Proceeds GrossProceeds	15000000	usd
CY2022Q2	rwod	Total Gross Proceeds TotalGrossProceeds	525000	usd
CY2022Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	8365339	usd
CY2022	rwod	Underwriting Fees UnderwritingFees	2875000	usd
CY2022	rwod	Deferred Underwriting Fees DeferredUnderwritingFees	4312500	usd
CY2022	rwod	Other Offering Costs OtherOfferingCosts	1177839	usd
CY2022Q2	rwod	Total Amount TotalAmount	116150000	usd
CY2022Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P185D
CY2022	rwod	Description Of Business Combination Percentage DescriptionOfBusinessCombinationPercentage	Pursuant to Nasdaq listing rules, the Company’s initial Business Combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.1
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.1
CY2022Q4	us-gaap	Cash Available For Distributions CashAvailableForDistributions	340962	usd
CY2022Q4	rwod	Working Capital Deficit WorkingCapitalDeficit	299788	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	rwod	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	28154705	usd
	rwod	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	3559	usd
CY2022	us-gaap	Dividends Cash DividendsCash	340962	usd
CY2021	us-gaap	Dividends Cash DividendsCash	4952	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	8365339	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1233352	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3559	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-29388057	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution and money market funds held in the Trust Account. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022	us-gaap	Interest Income Securities Us Treasury InterestIncomeSecuritiesUSTreasury	117806478	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	117806478	usd
CY2022Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	1500000	usd
CY2022Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P5Y
CY2022	us-gaap	Partners Capital Account Units Sold In Public Offering PartnersCapitalAccountUnitsSoldInPublicOffering	11500000	shares
CY2022	rwod	Gross Proceed GrossProceed	115000000	usd
CY2022Q4	rwod	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	-10695000	usd
CY2022Q4	rwod	Proceeds Allocated To Public Rights ProceedsAllocatedToPublicRights	-9430000	usd
CY2022Q4	rwod	Offering Costs Of Public Shares OfferingCostsOfPublicShares	-6901405	usd
CY2022	rwod	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	29388057	usd
CY2022	rwod	Class A Common Stock Subject To Possible Redemption ClassACommonStockSubjectToPossibleRedemption	117361652	usd
CY2022	rwod	Aggregate Private Units AggregatePrivateUnits	477500	shares
CY2022Q4	rwod	Sale Of Stock Price Per Shares SaleOfStockPricePerShares	10
CY2022	rwod	Aggregate Purchase Price AggregatePurchasePrice	4775000	usd
CY2022	rwod	Additional Aggregates Private Units AdditionalAggregatesPrivateUnits	52500	shares
CY2022	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	525000	usd
CY2022	rwod	Initial Stockholders Description InitialStockholdersDescription	The Initial Stockholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Insider Shares until, with respect to 50% of the Insider Shares, the earlier of six months after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a Business Combination and, with respect to the remaining 50% of the Insider Shares, until the six months after the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	90000	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	0	usd
CY2022	rwod	Accrued Expenses AccruedExpenses	90000	usd
CY2021	rwod	Accrued Expenses AccruedExpenses	0	usd
CY2022Q4	rwod	Prospectus To Purchase ProspectusToPurchase	1500000	shares
CY2022	us-gaap	Underwriting Expense Ratio UnderwritingExpenseRatio	0.025	pure
CY2022	rwod	Generating Gross Proceeds GeneratingGrossProceeds	2875000	usd
CY2022	rwod	Deferred Fee DeferredFee	0.0375	pure
CY2022Q4	us-gaap	Purchase Options Land PurchaseOptionsLand	100	usd
CY2022	rwod	Unit Purchase Option UnitPurchaseOption	345000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.5
CY2022	rwod	Aggregate Exercise Price AggregateExercisePrice	3967500	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	715303	usd
CY2022	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P5Y
CY2022	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	100	usd
CY2022	rwod	Right Of First Refusal Description RightOfFirstRefusalDescription	The Company has granted Chardan a right of first refusal, for a period of 18 months after the date of the consummation of a Business Combination, to act as a book-running manager or placement agent, with at least 30% of the economics, for any and all future public and private equity, equity linked and debt offerings of the Company or any of its successors or subsidiaries.
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3405000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3405000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	11500000	shares
CY2022Q4	rwod	Equity Method Investments Ownership Percentage EquityMethodInvestmentsOwnershipPercentage	0.60	pure
CY2022	rwod	Market Price Percentage MarketPricePercentage	1.15	pure
CY2022Q4	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	16.5
CY2022	rwod	Market Valuein Percentage MarketValueinPercentage	1.65	pure
CY2022Q4	rwod	Price Per Warrant PricePerWarrant	0.01
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	16.5
CY2022Q4	rwod	Warrants Liability WarrantsLiability	31800	usd
CY2022Q4	rwod	Fair Value FairValue	587717	usd
CY2022	rwod	Change In Fair Value ChangeInFairValue	-555917	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	31800	usd
CY2022Q2	rwod	Fair Value Of Private Warrants FairValueOfPrivateWarrants	587717	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2022Q4	rwod	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Underlying Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsUnderlyingSharePrice	10.06
CY2022Q2	rwod	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Underlying Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsUnderlyingSharePrice	8.08
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0297	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2562	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0399	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0242	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	112138	usd
CY2022Q4	rwod	Unrealized Gain On Investments Held In Trust Account UnrealizedGainOnInvestmentsHeldInTrustAccount	-78955	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33183	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	112138	usd
CY2022Q4	rwod	Deferred Tax Assetliability Net Of Allowance DeferredTaxAssetliabilityNetOfAllowance	78955	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	243070	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-33183	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	112138	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	322025	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0751	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0721	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.207	pure
CY2022Q4	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Intangible Assets DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets	112138	usd
CY2022	us-gaap	Federal State And Local Income Tax Expense Benefit Continuing Operations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations	322025	usd
CY2022Q4	us-gaap	Deferred Tax Assets Frequent Flier Liability DeferredTaxAssetsFrequentFlierLiability	78955	usd
	us-gaap	Federal State And Local Income Tax Expense Benefit Continuing Operations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	rwod	Payment Of Underwriters Commissions PaymentOfUnderwritersCommissions		usd
	rwod	Payment Of Deferred Offering Costs PaymentOfDeferredOfferingCosts		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
	rwod	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue		usd
	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges		usd
CY2022Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P5Y
CY2021Q4	rwod	Warrants Liability WarrantsLiability		usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001907223

Files In Submission

Name	View Source	Status
0001213900-23-028625-index-headers.html	Edgar Link	pending
0001213900-23-028625-index.html	Edgar Link	pending
0001213900-23-028625.txt	Edgar Link	pending
0001213900-23-028625-xbrl.zip	Edgar Link	pending
f10k2022ex21-1_redwoodsacq.htm	Edgar Link	pending
f10k2022ex31-1_redwoodsacq.htm	Edgar Link	pending
f10k2022ex31-2_redwoodsacq.htm	Edgar Link	pending
f10k2022ex32-1_redwoodsacq.htm	Edgar Link	pending
f10k2022ex32-2_redwoodsacq.htm	Edgar Link	pending
f10k2022ex4-8_redwoodsacq.htm	Edgar Link	pending
f10k2022_redwoodsacq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
f10k2022_redwoodsacq_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
rwod-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rwod-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
rwod-20221231_def.xml	Edgar Link	unprocessable
rwod-20221231_lab.xml	Edgar Link	unprocessable
rwod-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KLTO
Stock $klto

2023 Q2 Form 10-K Financial Statement

#000121390023028625 Filed on April 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLTO Stock $klto

2023 Q2 Form 10-K Financial Statement

#000121390023028625 Filed on April 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLTO
Stock $klto